Ausgabe Sonderheft 2/2003
1st Workshop of the International Society for Behçet's Disease (ISBD) on Pathophysiology and Treatment of Behçet's Disease
Inhalt (13 Artikel)
Perspectives of the Working Group on Drug Trials including Collaborative Trials of the ISBD and rationale for new clinical trials
S Assaad-Khalil
Cytotoxic drugs in ocular lesions of Behçet's disease
F Davatchi, F Shahram, H Chams, A Nadji, AR Jamshidi, C Chams, M Akbarian, F Gharibdoost, M Sedigh, B Sadeghi
The use of interferon-alfa in Behçet's disease: review of the literature
I Kötter, I Günaydin, M Zierhut, N Stübiger
Efficacy of recombinant human interferon-alfa2a on ocular and extra-ocular manifestations of Behçet's disease and influence on cells of the immune system: results of an open four center trial
I Kötter, M Treusch, R Vonthein, M Zierhut, A Eckstein, T Ness, I Günaydin, B Grimbacher, S Blaschke, HH Peter, N Stübiger
Migration of dendritic cells into the lymphatics: the Langerhans cell example
N Romani, P Stoitzner, S Ebner, H Stössel, S Holzmann, G Ratzinger, P Fritsch
Viral infection of retinal pigment epithelium: a possible role for initiation of Behçet's disease
EU Irschick, HP Huemer, C Larcher, R Sgonc, W Göttinger
Regulation of inflammatory CD28- T-helper cells by HLA class I molecules: a new cellular model for Behçet's disease?
C Duftner, C Goldberger, E Märker-Hermann, M Schirmer
Immunosuppressive effects of gemcitabine in the HSV-induced Behçet's disease like mouse model
S Sohn, M Lutz, HJ Kwon, G Konwalinka, S Lee, M Schirmer
Streptococcal antigen in the pathogenesis of Behçet's disease
F Kaneko, H Yanagihori, M Tojo, E Isogai, SN Lin, K Oguma